Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ATLAS (AltaValve) Pivotal Trial

NCT: NCT06465745 · RECRUITING

NCT IDNCT06465745
StatusRECRUITING
Start Date2024-09-03
Completion2031-09
Sponsor4C Medical Technologies, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.

Frequently Asked Questions

What is ATLAS (AltaValve) Pivotal Trial?

ATLAS (AltaValve) Pivotal Trial is a clinical trial registered under NCT06465745. Current status: RECRUITING.

What is the status of NCT06465745?

The current status of NCT06465745 (ATLAS (AltaValve) Pivotal Trial) is: RECRUITING.

When did ATLAS (AltaValve) Pivotal Trial start?

ATLAS (AltaValve) Pivotal Trial started on 2024-09-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.